Wealthcare Advisory Partners’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.13M Sell
8,903
-1,748
-16% -$221K 0.03% 452
2025
Q1
$1.36M Buy
10,651
+111
+1% +$14.2K 0.04% 377
2024
Q4
$1.39M Sell
10,540
-521
-5% -$68.9K 0.04% 345
2024
Q3
$1.61M Buy
11,061
+189
+2% +$27.5K 0.05% 311
2024
Q2
$1.49M Buy
10,872
+28
+0.3% +$3.84K 0.05% 291
2024
Q1
$1.49M Sell
10,844
-180
-2% -$24.7K 0.05% 283
2023
Q4
$1.5M Sell
11,024
-104
-0.9% -$14.1K 0.06% 243
2023
Q3
$1.36M Buy
11,128
+538
+5% +$65.8K 0.06% 231
2023
Q2
$1.34M Buy
10,590
+164
+2% +$20.8K 0.06% 239
2023
Q1
$1.35M Buy
10,426
+34
+0.3% +$4.39K 0.06% 240
2022
Q4
$1.36M Sell
10,392
-278
-3% -$36.5K 0.07% 222
2022
Q3
$1.25M Buy
10,670
+1,797
+20% +$210K 0.07% 203
2022
Q2
$1.04M Sell
8,873
-41
-0.5% -$4.82K 0.06% 199
2022
Q1
$1.16M Buy
8,914
+140
+2% +$18.3K 0.07% 168
2021
Q4
$1.34M Buy
8,774
+265
+3% +$40.4K 0.08% 155
2021
Q3
$1.38M Sell
8,509
-129
-1% -$20.9K 0.09% 144
2021
Q2
$1.41M Buy
8,638
+237
+3% +$38.8K 0.09% 142
2021
Q1
$1.27M Sell
8,401
-1,489
-15% -$224K 0.09% 139
2020
Q4
$1.5M Buy
9,890
+1,173
+13% +$178K 0.13% 94
2020
Q3
$1.18M Buy
8,717
+906
+12% +$123K 0.13% 101
2020
Q2
$1.07M Buy
7,811
+2,452
+46% +$335K 0.13% 98
2020
Q1
$577K Buy
5,359
+2,760
+106% +$297K 0.08% 135
2019
Q4
$313K Buy
2,599
+151
+6% +$18.2K 0.04% 233
2019
Q3
$244K Sell
2,448
-12
-0.5% -$1.2K 0.04% 238
2019
Q2
$268K Buy
2,460
+800
+48% +$87.2K 0.04% 221
2019
Q1
$186K Hold
1,660
0.03% 249
2018
Q4
$160K Sell
1,660
-114
-6% -$11K 0.03% 238
2018
Q3
$216K Sell
1,774
-14
-0.8% -$1.71K 0.04% 207
2018
Q2
$196K Buy
1,788
+1,514
+553% +$166K 0.04% 215
2018
Q1
$29K Buy
274
+121
+79% +$12.8K 0.01% 512
2017
Q4
$17K Sell
153
-18
-11% -$2K ﹤0.01% 571
2017
Q3
$19K Buy
+171
New +$19K 0.01% 439
2017
Q1
Sell
-84
Closed -$7K 122
2016
Q4
$7K Buy
+84
New +$7K ﹤0.01% 90